LOS ANGELES, June 18, 2019 (GLOBE NEWSWIRE) -- In an interview with Capital Market Laboratories (CMLviz), chief financial officer of Veeva Systems (VEEV) Tim Cabral had a clear message: Veeva is changing the game. It’s showing that there is a better way to manage clinical data in a trial. The company trades near-term growth for long-term growth, and the company has made that trade-off over the history of its existence to the benefit of shareholders.
Alicia Newman, Director Client Services
Capital Market Laboratories